Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JULY 20, 2023 SAM #7905
SOLICITATION NOTICE

66 -- Rapid Synthesis of Plasmids and Mutagensis for CVV Research

Notice Date
7/18/2023 2:54:37 AM
 
Notice Type
Solicitation
 
NAICS
541380 — Testing Laboratories
 
Contracting Office
CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
 
ZIP Code
30333
 
Solicitation Number
PR79011
 
Response Due
8/2/2023 1:00:00 PM
 
Archive Date
09/30/2023
 
Point of Contact
Castrinos, Nicholas, Phone: 8046611410
 
E-Mail Address
ugn8@cdc.gov
(ugn8@cdc.gov)
 
Description
As part of Centers for Disease Control and Prevention's (CDC�s) mission of influenza pandemic preparedness and response, the Influenza Division (ID) develops and delivers medical countermeasures. One such medical countermeasure are candidate vaccine viruses (CVVs), which are precursor vaccine products or seeds developed by partners within the World Health Organization (WHO) Global Influenza Surveillance and Responses System (GISRS). GISRS monitors human influenza disease burden, monitors antigenic drift and other changes (such as antiviral drug resistance) in seasonal influenza viruses, obtains suitable virus isolates for updating of influenza vaccines, and detects and obtains isolates of new influenza viruses infecting humans, especially those with pandemic potential to be use for research and vaccine development.� To facilitate the development of the CVVs, CDC uses oligonucleotides and synthetic genes to transcribe the influenza genes to produce the CVVs. ID requires plasmids and linear DNA to be developed routinely based on the constant changes in the genetic make-up of the circulating and novel viruses. These changes are unpredictable and cannot be identified until the viruses are isolated from patients or infected animals. Further, the synthesis of genes is often the rate limiting step in rapid reverse genetics (RG) CVV production, which is required to meet vaccine preparedness goals. Inquiries should be received at the Contracting Office no later than 21 July 2023, submitted via e-mail. See Section 4 (Inquiries) for specific instructions.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/37ed531aa8fc4180ae092af4bd3d4ff8/view)
 
Place of Performance
Address: Atlanta, GA 30333, USA
Zip Code: 30333
Country: USA
 
Record
SN06753939-F 20230720/230718230052 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.